$KMB · KIMBERLY CLARK CORP
Kimberly-Clark filed an 8-K with preliminary Q3 2026 results. Net sales slipped to $4,134M from $4,150M, with organic sales growth turning negative at -1.3%. Adjusted EPS from continuing operations rose to $1.70 from $1.45. The company reaffirmed its full-year 2026 outlook, including adjusted operating profit growth of mid-single digits on a constant-currency basis. Final Q3 results will be released November 5, 2026.
- Q3 2026 net sales estimated at $4,134M vs $4,150M a year ago, a slight decline.
- Organic sales growth turned negative at -1.3% vs +2.5% in Q3 2025.
- Adjusted EPS from continuing operations rose to $1.70 from $1.45, beating the prior year.
- GAAP diluted EPS attributable to KMB jumped to $5.37 from $1.34, likely including one-time items.
- FY26 outlook: organic sales ~100bps below category growth; adj operating profit mid-single-digit growth constant-currency.
Extended-hours trading shows KMB at $102.65, up +3.26% vs the regular close of $99.41, suggesting the market is rewarding the adjusted EPS beat and reaffirmed FY26 guidance despite the organic sales contraction.
A consumer-staples bellwether showing organic sales contraction yet beating on adjusted EPS — the divergence between top-line weakness and bottom-line resilience will be the central debate heading to
Kimberly-Clark's organic sales decline contrasts with its ~1.7% weighted average category growth, signaling market share pressure in consumer staples — a sector where pricing power and volume resilience are under scrutiny amid macro uncertainty.
China social media disruptions are flagged as a ~100bps headwind to organic sales growth. The pending Kenvue acquisition adds execution and financing risk, and the preliminary numbers remain unaudited with final Q3 results due November 5, 2026.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.